15.03.2014 Views

Acute disseminated encephalomyelitis mimicking brain lymphoma

Acute disseminated encephalomyelitis mimicking brain lymphoma

Acute disseminated encephalomyelitis mimicking brain lymphoma

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

ACUTE DISSEMINATED ENCEPHALOMYELITIS<br />

MIMICKING BRAIN LYMPHOMA<br />

Saleh Al Ajlouni MD*, Mahmoud Alawneh MD*, Wael Khresat MD*, Rawan Tarawneh MD*<br />

ABSTRACT<br />

We report here on a 10-years-old female patient, previously healthy, presented with a short history of<br />

neurological symptoms, among which ataxic gait, headache, recurrent falling down and inability to move left<br />

leg were found. Initial diagnosis was <strong>brain</strong> <strong>lymphoma</strong> depending on the <strong>brain</strong> MRI findings. CT scan of the<br />

chest, abdomen, and pelvis were normal. Bone marrow biopsy showed no bone marrow involvement by<br />

<strong>lymphoma</strong> or leukemia. Brain biopsy was performed and showed evidence of demyelination but no evidence<br />

of malignancy. <strong>Acute</strong> <strong>disseminated</strong> <strong>encephalomyelitis</strong> became a very likely diagnosis on the basis of the<br />

clinical, <strong>brain</strong> MRI and biopsy findings. The patient was started on methylprednisolone pulse therapy for five<br />

days after which she gradually improved regarding her gait and neurological status and general well being. A<br />

follow up <strong>brain</strong> MRI revealed significant improvement. She was followed up and she was back to normal over<br />

four weeks duration. We conclude that acute <strong>disseminated</strong> <strong>encephalomyelitis</strong> may present as <strong>lymphoma</strong> and<br />

should be considered in the differential diagnosis.<br />

Key word: ADEM, Children, Jordan.<br />

JRMS February 2010; 17(Supp 1): 35-38<br />

Case Report<br />

RS, a 10-year-old female patient, previously<br />

healthy, presented with a 5-day history of ataxic<br />

gait, headache and recurrent falling down many<br />

times per day. She was unable to move her left leg<br />

and dragged it behind her when she attempted<br />

walking.<br />

She had recurrent vomiting on the day of<br />

admission. She also reported a history of an upper<br />

respiratory tract infection two weeks prior to her<br />

admission. There were no other neurological or<br />

systemic complaints. Her family’s history was<br />

unremarkable.<br />

Her general physical examination revealed a<br />

mildly congested throat. She looked ill and did not<br />

respond fully to questions, but was conscious and<br />

oriented.<br />

The power was 4/5 in her left leg, normal on the<br />

right side. Reflexes were +3 bilaterally. She was<br />

also found to have positive Romberg’s sign. Sensory<br />

examination was normal without the presence of<br />

sensory level but impaired proprioception; planters<br />

were up going in both lower limbs, neurological<br />

examination of the upper limbs was normal.<br />

The patient was admitted to hospital and<br />

investigated. Her complete blood picture, renal and<br />

liver profile, serum electrolytes, sugar and<br />

coagulation profiles were normal. CSF studies were<br />

normal and oligoclonal band was negative. Viral<br />

CSF study (mosaic biochip CNS profile) was<br />

normal. CT scan of the chest, abdomen, and pelvis<br />

were normal, bone marrow biopsy showed no bone<br />

marrow involvement by <strong>lymphoma</strong> or leukemia.<br />

Alpha-feto protein level was 0.9 mg/ml and HCG<br />

*From the Department of Pediatrics, King Hussein Medical Center, (KHMC), Amman-Jordan<br />

Correspondence should be addressed to Dr. S. Al-Ajlouni, (KHMC), E-mail salehajlouni@hotmail.com<br />

Manuscript received November 28, 2005. Accepted March 16, 2006<br />

JOURNAL OF THE ROYAL MEDICAL SERVICES<br />

Vol. 17 Supp No. 1 February 2010<br />

35


Fig. 1. Brain MRI showed large irregular hypo-intense lesions on T1W and hyper-intense lesions in T2W at the<br />

gray-white matter junctions in both parietal and both frontal lobes extending to the periventricular white matter. The<br />

lesions show irregular and inhomogeneous enhancement pattern, suggestive of <strong>brain</strong> <strong>lymphoma</strong>.<br />

Fig. 2a, b. Brain MRI after treatment revealed hyper-intense lesions on T2 WI that were significantly smaller in size<br />

and there was no evidence of any new lesions and no evidence of enhancement in these lesions<br />

was less than 5.0 MI/ML. Immunoglobulin<br />

electrophoresis, and serology for HIV and TORCH<br />

were all normal. Visual evoked potentials showed<br />

normal bilateral P100 pattern.<br />

Brain CT revealed white matter hypodensities<br />

symmetrically in both parietal regions. Brain MRI<br />

was done for better evaluation and showed large<br />

irregular hypo-intense lesions at T1W, and hyper<br />

intense in T2W at the gray-white matter junctions in<br />

both parietal and both frontal lobes extending to the<br />

periventricular white matter mainly seen to the left<br />

side. Lesions show irregular and inhomogeneous<br />

enhancement pattern, suggestive of <strong>brain</strong> <strong>lymphoma</strong><br />

as shown in Fig. 1. Fundoscopy examination was<br />

normal. Brain biopsy was performed which showed<br />

evidence of demyelination with no evidence of<br />

malignancy.<br />

In view of this, acute <strong>disseminated</strong><br />

<strong>encephalomyelitis</strong> became a very likely diagnosis<br />

on the basis of the clinical, Brain MRI and biopsy<br />

finding. The patient was started on methyl<br />

prednisolone pulse therapy for five days after which<br />

she gradually improved regarding her gait and<br />

neurological status and general well being. On her<br />

next visit to the clinic two weeks later, her clinical<br />

examination showed that her gait and neurological<br />

exam were back to normal. A repeat <strong>brain</strong> MRI<br />

revealed hyper-intense lesions on T2 WI that were<br />

significantly smaller in size and there was no<br />

evidence of any new lesions and there was no<br />

evidence of enhancement in these lesions.<br />

Significant improvement was noted (see Fig. 2a and<br />

2b).<br />

The patient was followed up later for many times<br />

in the outpatient clinic with normal general and<br />

neurological examination.<br />

Discussion<br />

Many reports, coming from all parts of the world<br />

have been recently published on the characteristics<br />

of acute <strong>disseminated</strong> <strong>encephalomyelitis</strong> (ADEM) in<br />

children. (1,2,3)<br />

36<br />

JOURNAL OF THE ROYAL MEDICAL SERVICES<br />

Vol. 17 Supp No. 1 February 2010


Table I. Different definitions of ADEM used in recently published series of pediatric and adult patients<br />

Author<br />

Definition<br />

Dale et al (1) Inflammatory disease at multiple sites within the CNS, either monophasic or multiphasic if<br />

relapses are thought to represent part of acute monophasic immune process<br />

Hynson et al (2) <strong>Acute</strong> onset of neurological disturbance and MRI changes involving the white matter in<br />

distribution consistent with ADEM<br />

Murphy et al (4) <strong>Acute</strong> onset of neurological signs and symptoms together with MRI evidence of multifocal,<br />

hyperintense lesions on the flair and T2 weighted images<br />

Tenenbaum et al (9) Occurrence of presumed inflammatory demyelinating event of acute or subacute onset,<br />

affecting multifocal areas of the CNS with polsymptomatic presentation in an individual who<br />

has no history of neurological symptoms suggestive of earlier demyelinating episodes. the<br />

patient has to show white matter changes without radiological evidence of previous<br />

destructive white matter process.<br />

Mikaeloff et al (10) A first demyelinating event with polysymptomatic onset with mental state change and a<br />

suggestive <strong>brain</strong> MRI (poorly limited lesions associated, at a time, with thalamus and/or basal<br />

ganglia lesions) with exclusion of infections and systemic disorders.<br />

Schwartz et al (3) <strong>Acute</strong> neurological symptoms without a history of previous unexplained neurological<br />

symptoms. One or multiple supra or infratentorial demyelinating lesions. Absence of black<br />

holes on T1-weighted MRI (as sign of a previous destructive inflammatory demyelinating<br />

process), exclusion of cerebrospinal fluid infection, vasculitis or other autoimmune disease.<br />

No evidence of a second clinical episode of CNS demyelination.<br />

Anlar et al (14) Diffuse or multifocal neurological findings of acute or subacute onset associated with diffuse<br />

or multiple areas of increased signal intensity on T2 weighted MRI involving the white matter<br />

or central grey matter.<br />

Table II. Preceding infectious illnesses<br />

A. Infections B. Vaccines<br />

* Viral<br />

* Rabies<br />

* Measles<br />

* Diphtheria, tetanus, pertussis<br />

* Mumps<br />

* Smallpox<br />

* Influenza A or B<br />

* Measles<br />

* Hepatitis A or B<br />

* Japanese B encephalitis.<br />

* Herpes simplex<br />

* Polio<br />

* Human herpes virus E<br />

* Hepatitis B<br />

* Varicella, rubella<br />

* Influenza.<br />

* Epstein-Barr virus<br />

* Cytomegalovirus<br />

* HIV<br />

*Others<br />

* Mycoplasma pneumoniae<br />

* Chlamydia<br />

* Legionella<br />

* Campylobacter<br />

* Streptococcus<br />

ADEM has no internationally recognized definition<br />

or diagnostic criteria. Attempts to unify these<br />

criteria were made by seven out of the eleven<br />

published case reports (six children and one adult)<br />

which used nearly similar but slightly different<br />

definitions (see Table I). It is usually preceded by<br />

viral infection or vaccinations and has a wide<br />

clinical spectrum ranging from subclinical episode<br />

to a rapidly progressive disease culminating in<br />

seizure and coma. (1,3) In our case there was a history<br />

of upper respiratory tract infection two weeks prior<br />

to presentation. Viral and bacterial infections and<br />

vaccines that have been implicated in ADEM are<br />

listed in Table II. Patients may present with<br />

different neurological manifestation like optic<br />

neuritis, hemiparesis, cranial nerves palsies and<br />

ataxia. The diagnosis is usually made based on<br />

clinical symptoms and is confirmed by MRI<br />

findings.<br />

In the absence of a biological marker, the<br />

distinction between ADEM and MS cannot be made<br />

with certainty at the time of the first presentation. A<br />

JOURNAL OF THE ROYAL MEDICAL SERVICES<br />

Vol. 17 Supp No. 1 February 2010<br />

37


viral prodrome, early onset of ataxia, highly lesions<br />

load on the MRI, involvement of the deep gray<br />

matter and absence of oligo-colonal bands are more<br />

indicative of ADEM. (4,5) Although ADEM is<br />

typically a monophasic illness, it is difficult to be<br />

distinguished from an acute attack of multiple<br />

sclerosis (MS). (6) Lesions on the thalamus are<br />

described more often in ADEM than MS. (7) In our<br />

case report <strong>brain</strong> <strong>lymphoma</strong> was greatly suspected<br />

and tumour-like lesions have been reported in a few<br />

patients. (8) Treatment of ADEM is based on<br />

intravenous administration of steroids, which<br />

usually leads to a favorable outcome. (9,10,11)<br />

In some cases where corticosteroids have failed to<br />

work the use of immunoglobulin and Plasmapheresis<br />

has been shown to produce dramatic<br />

(12, 13)<br />

improvement.<br />

References<br />

1. Dale RC, de Sousa C, Chong WK, et al. <strong>Acute</strong><br />

<strong>disseminated</strong> <strong>encephalomyelitis</strong>, multiphasic<br />

<strong>disseminated</strong> <strong>encephalomyelitis</strong> and multiple<br />

sclerosis in children. Brain 2000; 12:2407-22.<br />

2. Hynson JL, Kornberg AJ, Coleman LT, et al.<br />

Clinical and neuroradiologic features of acute<br />

<strong>disseminated</strong> <strong>encephalomyelitis</strong> in children.<br />

Neurology 2001; 56:1308-1312.<br />

3. Schwarz S, Mohr A, Knauth M, et al. <strong>Acute</strong><br />

<strong>disseminated</strong> <strong>encephalomyelitis</strong>: A follow-up study<br />

of 40 adult patients. Neurology 2001; 56:1313-<br />

1318.<br />

4. Murthy JMK, Yangala R, Meena AK, et al.<br />

<strong>Acute</strong> <strong>disseminated</strong> <strong>encephalomyelitis</strong>: (clinical<br />

and MRI study from South India). J Neurol Sci<br />

1999; 165: 133-138.<br />

5. Hynson JL, Kornberg AJ, Coleman LT, et al.<br />

Clinical and neuroradiologic features of acute<br />

<strong>disseminated</strong> <strong>encephalomyelitis</strong> in children.<br />

Neurology 2001; 56: 1257-1260.<br />

6. Bernarding j, Braun j, Koennecke HC. Diffusion<br />

and perfusion weighted MRI imaging in a patient<br />

with acute <strong>disseminated</strong> <strong>encephalomyelitis</strong><br />

(ADEM). J Magn Reson Imaging 2002; 15(1):96-<br />

100.<br />

7. Barkhof F, Fillipi M, Miller DH, et al.<br />

Comparison of MRI criteria at presentation to<br />

predict conversion to clinically definite multiple<br />

sclerosis. Brain 1997; 120: 2059-2069.<br />

8. Garg RK. <strong>Acute</strong> <strong>disseminated</strong> <strong>encephalomyelitis</strong>:<br />

Postgraduate Medical Journal 2003; 79:11-17.<br />

9. Tenembaum S, Chamoles N, Fejerman N. <strong>Acute</strong><br />

<strong>disseminated</strong> <strong>encephalomyelitis</strong>. A long-term<br />

follow-up study of 84 pediatric patients. Neurology<br />

2002; 59:1224-1231.<br />

10. Mikaeloff Y, Suissa S, Vallee L, et al. First<br />

episode of acute CNS inflammatory demyelination<br />

in childhood: prognostic factors for multiple<br />

sclerosis and disability. J Pediatric 2004; 144(2):<br />

246-252.<br />

11. Murthy SN, Faden HS, Cohen EM, Bakshi R.<br />

<strong>Acute</strong> <strong>disseminated</strong> <strong>encephalomyelitis</strong> in children<br />

Pediatrics 2002; 110: 21-28.<br />

12. Stonehouse M, Gupte G, Wassmer E,<br />

Whitehouse WP. <strong>Acute</strong> <strong>disseminated</strong><br />

<strong>encephalomyelitis</strong>: recognition in the hands of<br />

general pediatricians. Arch Dis Child 2003; 88:<br />

122-124.<br />

13. Properzi E, Spalice A, Terenzi S, et al. <strong>Acute</strong><br />

<strong>disseminated</strong> <strong>encephalomyelitis</strong>. Ital J Pediatr<br />

2003; 29: 18-21.<br />

14. Anlar B, Basaran C, Kose G, et al. <strong>Acute</strong><br />

<strong>disseminated</strong> <strong>encephalomyelitis</strong> in children<br />

outcome and prognosis. Neuropediatrics 2003;<br />

34(4): 194-199.<br />

38<br />

JOURNAL OF THE ROYAL MEDICAL SERVICES<br />

Vol. 17 Supp No. 1 February 2010

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!